Lipocine Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.47 | — | — | Miss |
| Q12026 FY2026 | $-0.51 | $-0.54 | -5.9% | Miss |
| Q42025 FY2025 | $-0.60 | $-0.34 | +43.3% | Beat |
Back to LPCN overview · LPCN holders · LPCN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.